Pharmaceuticals & Medical Research Sector — activité des initiés

Suivez les achats et ventes d’initiés sur les actions de Healthcare. Découvrez quels dirigeants achètent, l’activité nette des initiés et le pourcentage du flottant échangé parmi 2,192 sociétés.
Les informations fournies dans ce classement sont à titre informatif uniquement et ne constituent pas un conseil financier. Nous ne recommandons aucun investissement spécifique basé sur ces critères.
Entreprises
Données
Abonnez-vous pour accéder à l'ensemble des données
Entreprise Branche d'activité Cap. boursière ($) # acheteurs nets Valeur nette achetée ($) % du flottant acheté % d'actions détenues par les initiés
Pharmaceuticals Mega (1.3tn) 0 Aucune activité — 0–15%
Pharmaceuticals Mega (664.9bn) -1–5 -$10M–$100M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals Mega (513.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Mega (368.9bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals Mega (311.2bn) 0 Aucune activité — —
CH Novartis AG (NOVN)
Pharmaceuticals Mega (303.2bn) -1–5 -$100K–$1M -0–15% 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals Mega (249.4bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals Mega (249.4bn) 1–5 $10M–$100M 0–15% 0–15%
Pharmaceuticals Mega (207.0bn) 0 Aucune activité — 0–15%
DK Novo Nordisk A/S (NOVO-B)
Pharmaceuticals Mega (201.4bn) 0 Aucune activité — 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals Large (174.0bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals Large (137.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (128.8bn) -1–5 -$1M–$10M -0–15% 0–15%
US Moderna Inc (MRNA)
Biotechnology & Medical Research Large (101.5bn) 0 Aucune activité — 0–15%
FR Sanofi SA (SAN)
Pharmaceuticals Large (97.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (93.4bn) -1–5 -$10M–$100M -0–15% 0–15%
GB GSK plc (GSK)
Pharmaceuticals Large (92.8bn) 11–20 $100K–$1M 0–15% 0–15%
AU CSL Ltd (CSL)
Pharmaceuticals Large (90.6bn) 0 Aucune activité — 0–15%
US Celgene Corp (CELG)
Pharmaceuticals Large (77.0bn) 0 Aucune activité — —
US Allergan plc (AGN)
Pharmaceuticals Large (63.7bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (62.0bn) 0 Aucune activité — 0–15%
BE Ucb SA (UCB)
Pharmaceuticals Large (61.9bn) 1–5 < $100K 0–15% 15–50%
DE Bayer AG (BAYN)
Pharmaceuticals Large (60.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (60.7bn) -6–10 -$10M–$100M -0–15% 0–15%
Biotechnology & Medical Research Large (56.6bn) -1–5 -$1M–$10M -0–15% 0–15%
NL argenx SE (ARGX)
Biotechnology & Medical Research Large (55.9bn) -6–10 -$10M–$100M -0–15% 0–15%
Pharmaceuticals Large (51.5bn) 0 Aucune activité — 50%+
Biotechnology & Medical Research Large (44.8bn) -1–5 -$100K–$1M -0–15% 0–15%
US Seagen Inc (SGEN)
Biotechnology & Medical Research Large (43.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (42.0bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (39.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Large (39.0bn) 0 Aucune activité — 0–15%
GB Haleon PLC (HLN)
Pharmaceuticals Large (37.7bn) 1–5 $100K–$1M 0–15% 0–15%
US Biogen Inc (BIIB)
Pharmaceuticals Large (36.8bn) 0 Aucune activité — 0–15%
KR Celltrion, Inc. (068270)
Biotechnology & Medical Research Large (32.7bn) -1–5 -$1M–$10M -0–15% 15–50%
Pharmaceuticals Large (32.0bn) 0 Aucune activité — 50%+
Pharmaceuticals Large (29.2bn) 1–5 -$100K–$1M -0–15% 50%+
US Zoetis Inc (ZTS)
Pharmaceuticals Large (28.9bn) 0 Aucune activité — 0–15%
DK Genmab A/S (GMAB)
Biotechnology & Medical Research Large (27.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (26.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (25.9bn) -1–5 -$10M–$100M -0–15% 15–50%
US Incyte Corp (INCY)
Pharmaceuticals Large (24.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Large (24.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Large (23.9bn) -1–5 -$100K–$1M -0–15% 0–15%
DE Biontech SE (BNTX)
Biotechnology & Medical Research Large (23.1bn) -1–5 -$10M–$100M -0–15% 50%+
US Viatris Inc (VTRS)
Pharmaceuticals Large (22.8bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (22.4bn) -6–10 -$10M–$100M -0–15% 0–15%
Biotechnology & Medical Research Large (21.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Large (20.3bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (20.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (19.4bn) 0 Aucune activité — 50%+
Biotechnology & Medical Research Large (18.8bn) -6–10 -$100M+ -0–15% 15–50%
Pharmaceuticals Large (17.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Large (17.3bn) -1–5 -$100K–$1M -0–15% 0–15%
US Exelixis Inc (EXEL)
Biotechnology & Medical Research Large (17.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (16.8bn) 0 Aucune activité — 0–15%
IN Cipla Ltd (CIPLA)
Pharmaceuticals Large (15.9bn) 0 Aucune activité — 15–50%
IE ICON PLC (ICLR)
Biotechnology & Medical Research Large (15.3bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Large (15.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Large (14.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals Large (14.8bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (14.2bn) -6–10 -$10M–$100M -0–15% 15–50%
Biotechnology & Medical Research Large (14.0bn) 0 Aucune activité — 0–15%
FR Ipsen SA (IPN)
Pharmaceuticals Large (14.0bn) 1–5 $100K–$1M 0–15% 50%+
Pharmaceuticals Large (13.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (13.2bn) 0 Aucune activité — 50%+
Pharmaceuticals Large (13.1bn) 0 Aucune activité — 50%+
FI Orion Oyj (ORNBV)
Pharmaceuticals Large (13.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (12.9bn) 0 Aucune activité — 50%+
Biotechnology & Medical Research Large (12.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (12.3bn) -1–5 -$10M–$100M -0–15% 15–50%
US MyoKardia Inc (MYOK)
Biotechnology & Medical Research Large (12.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (11.9bn) 0 Aucune activité — 15–50%
Pharmaceuticals Large (11.6bn) -1–5 -$1M–$10M -0–15% 0–15%
US Catalent Inc (CTLT)
Pharmaceuticals Large (11.5bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (11.4bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (11.3bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals Large (11.2bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (11.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Large (11.0bn) 0 Aucune activité — 15–50%
Biotechnology & Medical Research Large (10.9bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (10.9bn) 0 Aucune activité — 50%+
Pharmaceuticals Large (10.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Biotechnology & Medical Research Large (10.3bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (10.2bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Large (10.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Biotechnology & Medical Research Mid (9.9bn) 0 Aucune activité — 50%+
Biotechnology & Medical Research Mid (9.8bn) 0 Aucune activité — 0–15%
US Vaxcyte Inc (PCVX)
Biotechnology & Medical Research Mid (9.8bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Mid (9.6bn) 0 Aucune activité — 15–50%
Biotechnology & Medical Research Mid (9.3bn) -1–5 $10M–$100M 0–15% 0–15%
Biotechnology & Medical Research Mid (9.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Biotechnology & Medical Research Mid (9.1bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Mid (9.0bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Mid (9.0bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals Mid (9.0bn) -6–10 -$10M–$100M -0–15% 0–15%
Pharmaceuticals Mid (8.9bn) -1–5 -$1M–$10M -0–15% 0–15%
US ImmunoGen Inc (IMGN)
Biotechnology & Medical Research Mid (8.7bn) 0 Aucune activité — 0–15%
US Mylan NV (MYL)
Pharmaceuticals Mid (8.6bn) 0 Aucune activité — 0–15%
Biotechnology & Medical Research Mid (8.4bn) 0 Aucune activité — 0–15%